Reuters logo
BRIEF-AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY
2017年9月13日 / 下午5点02分 / 7 天前

BRIEF-AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

Sept 13 (Reuters) - Agilent Technologies Inc:

* AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

* AGILENT TECHNOLOGIES INC - ‍ASSAY IS INTENDED FOR USE ON AGILENT SURESCAN DX MICROARRAY SCANNER SYSTEM​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below